Human hepatocellular carcinoma tumor xenografts. Their androgen-receptor status and growth responses to castration
- PMID: 3349894
- DOI: 10.1007/BF01536034
Human hepatocellular carcinoma tumor xenografts. Their androgen-receptor status and growth responses to castration
Abstract
Castrated or sham-operated male athymic mice were inoculated with cells from the human hepatocellular carcinoma cell line PLC/PRF/5. There were no significant differences between the two groups with respect to the number of animals developing tumors, the time to tumor development, or the subsequent rate of increase in either tumor base area or mouse serum alpha-fetoprotein concentration. Androgen receptors were assayed in nuclei obtained from three separate liver cancer cell lines and from normal adult human liver. Similar concentrations, ranging from 235 to 550 fmol/mg DNA, of nuclear androgen receptors were detected in all tissues. Low percentages of androgen receptors were retained on DNA-cellulose. Although the presence of receptors implies the potential for metabolic effects of androgens in normal and malignant liver, our in vivo studies suggest that castration does not alter significantly the growth of liver cancer xenografts in athymic mice.
Similar articles
-
Effects of castration and androgen replacement on tumour growth of human hepatocellular carcinoma in nude mice.J Hepatol. 1996 Sep;25(3):362-9. doi: 10.1016/s0168-8278(96)80123-1. J Hepatol. 1996. PMID: 8895016
-
NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.Cancer Res. 2004 Aug 1;64(15):5489-95. doi: 10.1158/0008-5472.CAN-03-3117. Cancer Res. 2004. PMID: 15289359
-
Effect of serial passage in female nude athymic mice on androgen dependency of Shionogi carcinoma 115.Cancer Res. 1980 Dec;40(12):4781-5. Cancer Res. 1980. PMID: 7438110
-
Transplantable human prostatic carcinoma (PC-82) in athymic nude mice. II. Tumor growth and androgen receptors.Prostate. 1988;12(2):145-56. doi: 10.1002/pros.2990120205. Prostate. 1988. PMID: 3368403
-
Androgen receptor (AR) expression in prostate cancer and progression of the tumor: Lessons from cell lines, animal models and human specimens.Steroids. 2012 Aug;77(10):996-1001. doi: 10.1016/j.steroids.2012.01.008. Epub 2012 Jan 24. Steroids. 2012. PMID: 22289337 Review.